ArticleOpen forum infectious diseases2025

Sustained HIV Viral Suppression 18 Months After the Last Dose of Long-acting Cabotegravir/Rilpivirine: A Case Report.

Shawnalyn W Sunagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.